Perbedaan Diagnos Laboratorium Utama Tbk. dan Merck Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 5,4× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 33,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | MERK | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 1,68 T |
Volume | 963,6 rb | 33,3 rb |
Lot | 9,64 rb | 333 |
Perputaran | 217,67 jt | 126,46 jt |
Harga Rata-rata | 225,89 | 3.797,72 |
Nilai Transaksi | 217,67 jt | 126,46 jt |
Harga Ekuilibrium Indikatif | 226 | 3.800 |
Volume Ekuilibrium Indikatif | 1 rb | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →